Analyst Sees Neptune As Strong Buy; Increases Price Target to $9.25

Shares of Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT) (TSX.NTB) traded as high as $4.88 on Wednesday but sold off with the overall markets at the end of the day following a published research report update by Robin Cornwell of Catalyst Research. In the note, Cornwell increased his 12 month price target to $9.25 from $8.75...

New York, 19/07/2012 (informazione.news - comunicati stampa - varie) Shares of Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT) (TSX.NTB) traded as high as $4.88 on Wednesday but sold off with the overall markets at the end of the day following a published research report update by Robin Cornwell of Catalyst Research.

In the note, Cornwell increased his 12 month price target to $9.25 from $8.75.  After recent fundamental developments announced by the company, the research firm revised their fiscal 2013 and 2014 forecasts and introduced new fiscal 2015 projections.


Copyright Thomson Reuters


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: %s via Thomson Reuters ONE